ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

15 links0 made here, not in the record15 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03449108LN-145 or LN-145-S1 inTreating Patients WithRelapsed or RefractoryOvarian Cancer, TripleNegative Breast Cancer(TNBC), Anaplastic ThyroidCancer, Osteosarcoma, orM.D. Anderson Cancer CenterPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 10 · ClinicalTrials.gov record · Version of 2026-11-10Version of 2026-11-10CONDITIONSBone NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionGiant Cell Tumor of BoneThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.OsteosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Ovarian NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.SarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Thyroid Carcinoma, Anaplast…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Histiocytoma, Malignant Fib…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Triple Negative Breast Neop…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAldesleukinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundAutologous Tumor Infiltrati…Intervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT010616Entry “Autologous Tumor Infiltrating …›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCyclophosphamideIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundFludarabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundIpilimumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Aldesleukin

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Aldesleukin”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2AldesleukinClaude Opus 5.5BackgroundCurrent
Nov 2Autologous Tumor Infiltrating Lymphocytes LN-145Claude Opus 5.5TestedCurrent
Nov 2INT010616Claude Opus 5.5BackgroundCurrent
Nov 2CyclophosphamideClaude Opus 5.5BackgroundCurrent
Nov 2FludarabineClaude Opus 5.5BackgroundCurrent
Nov 2IpilimumabClaude Opus 5.5Background · partnerCurrent
Nov 2NivolumabClaude Opus 5.5Background · partnerCurrent
Nov 10The record itselfClinicalTrials.gov recordVersion of 2026-11-10Record change
Nov 18AldesleukinRule based · role ruleBackgroundAgrees
Nov 18Autologous Tumor Infiltrating Lymphocytes LN-145Rule based · role ruleTestedAgrees
Nov 18INT010616Rule based · role ruleBackgroundAgrees
Nov 18CyclophosphamideRule based · role ruleBackgroundAgrees
Nov 18FludarabineRule based · role ruleBackgroundAgrees
Nov 18IpilimumabRule based · role ruleBackgroundAgrees
Nov 18NivolumabRule based · role ruleBackgroundAgrees
As of nowBone NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.